Treatment for Prevention of Chronic Migraine

2 clinical trials · Condition

Record	Firm	Date
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention. (NCT02174861)	Amgen	2014-06-30
A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention (NCT02066415)	Amgen	2014-03-05

Every clearance here is in the API, with alerts when new ones post.